Published ahead of print on May 28, 2003, doi:10.1164/rccm.200212-1440OC
American Journal of Respiratory and Critical Care Medicine Vol 168. pp. 335-341, (2003)
© 2003 American Thoracic Society
Cellular Antiendotoxin Activities of Lung Surfactant Protein C in Lipid Vesicles
Luis A. Augusto,
Monique Synguelakis,
Quentin Espinassous,
Michel Lepoivre,
Jan Johansson and
Richard Chaby
Endotoxin Group, and Laboratory of Nitrogen Oxides Inflammation and Immunity, UMR-8619, National Center for Scientific Research, University of Paris-Sud, Orsay, France; and Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
Correspondence and requests for reprints should be addressed to Richard Chaby, M.D., Equipe Endotoxines, UMR-8619 du CNRS, Bâtiment 430, Université de Paris-Sud, 91405 Orsay, France. E-mail: richard.chaby{at}bbmpc.u-psud.fr
The respiratory system is continuously exposed to airborne particles containing lipopolysaccharide. Our laboratory established previously that the hydrophobic surfactant protein C (SP-C) binds to lipopolysaccharide and to one of its cellular receptors, CD14. Here we examined the influence of SP-C, and of a synthetic analog, on some cellular in vitro effects of lipopolysaccharide. When associated with vesicles of dipalmitoylphosphatidylcholine, SP-C inhibits the binding of a tritium-labeled lipopolysaccharide to the macrophage cell line RAW 264.7. Under similar conditions of presentation, SP-C inhibits the mitogenic effect of lipopolysaccharide on mouse splenocytes, and inhibits the lipopolysaccharide-induced production of tumor necrosis factor- by peritoneal and alveolar macrophages, and of nitric oxide by RAW 264.7 cells. In contrast, tumor necrosis factor- production induced by a lipopeptide, and nitric oxide production induced by picolinic acid, were not affected by SP-C. The lipopolysaccharide-binding capacity of SP-C is resistant to peroxynitrite, a known mediator of acute lung injury formed by reaction of nitric oxide with superoxide anions. These results indicate that SP-C may play a role in lung defense; SP-C resists degradation under inflammatory conditions and traps lipopolysaccharide, preventing it from inducing production of noxious mediators in alveolar cells.
Key Words: lipopolysaccharide nitric oxide peroxynitrite surfactant protein-C tumor necrosis factor-
This article has been cited by other articles:

|
 |

|
 |
 
S. W. Glasser, A. P. Senft, J. A. Whitsett, M. D. Maxfield, G. F. Ross, T. R. Richardson, D. R. Prows, Y. Xu, and T. R. Korfhagen
Macrophage Dysfunction and Susceptibility to Pulmonary Pseudomonas aeruginosa Infection in Surfactant Protein C-Deficient Mice
J. Immunol.,
July 1, 2008;
181(1):
621 - 628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ramirez, A. Santana, A. Cruz, I. Plasencia, and G. E. Lopez
Molecular Dynamics of Surfactant Protein C: From Single Molecule to Heptameric Aggregates
Biophys. J.,
April 15, 2006;
90(8):
2698 - 2705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rety, S. Salamitou, I. Garcia-Verdugo, D. J. S. Hulmes, F. Le Hegarat, R. Chaby, and A. Lewit-Bentley
The Crystal Structure of the Bacillus anthracis Spore Surface Protein BclA Shows Remarkable Similarity to Mammalian Proteins
J. Biol. Chem.,
December 30, 2005;
280(52):
43073 - 43078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Chaby, I. Garcia-Verdugo, Q. Espinassous, and L. A. Augusto
Interactions between LPS and lung surfactant proteins
Innate Immunity,
June 1, 2005;
11(3):
181 - 185.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Whitsett, C. J. Bachurski, K. C. Barnes, P. A. Bunn Jr., L. M. Case, D. N. Cook, D. Crooks, M. W. Duncan, L. Dwyer-Nield, R. C. Elston, et al.
Functional Genomics of Lung Disease
Am. J. Respir. Cell Mol. Biol.,
August 1, 2004;
31(2/S1):
S1 - S81.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. van Kaam, R. A. Lachmann, E. Herting, A. De Jaegere, F. van Iwaarden, L. A. Noorduyn, J. H. Kok, J. J. Haitsma, and B. Lachmann
Reducing Atelectasis Attenuates Bacterial Growth and Translocation in Experimental Pneumonia
Am. J. Respir. Crit. Care Med.,
May 1, 2004;
169(9):
1046 - 1053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Raychaudhuri, S. Abraham, T. L. Bonfield, A. Malur, A. Deb, J. A. DiDonato, M. S. Kavuru, and M. J. Thomassen
Surfactant Blocks Lipopolysaccharide Signaling by Inhibiting both Mitogen-Activated Protein and I{kappa}B Kinases in Human Alveolar Macrophages
Am. J. Respir. Cell Mol. Biol.,
February 1, 2004;
30(2):
228 - 232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Critical Care Medicine in AJRCCM 2003
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
239 - 253.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2003
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
277 - 287.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society
|
|
|